Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Pharma drug reduces blood fat by 64 pct in mid-stage study
Isis Pharma drug reduces blood fat by 64 pct in mid-stage study
Isis Pharma drug reduces blood fat by 64 pct in mid-stage study
Submitted by
admin
on July 22, 2013 - 10:45am
Source:
Reuters
News Tags:
Isis Pharmaceuticals
hypertriglyceridemia
ISIS-APOCIIIRx
Headline:
Isis Pharma drug reduces blood fat by 64 pct in mid-stage study
Do Not Allow Advertisers to Use My Personal information
